HEADER TRANSFERASE/TRANSFERASE ACTIVATOR 06-SEP-13 4MLH TITLE HUMAN GLUCOKINASE IN COMPLEX WITH A NOVEL AMINO THIAZOLE ALLOSTERIC TITLE 2 ACTIVATOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOKINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SEE REMARK 999; COMPND 5 SYNONYM: HEXOKINASE TYPE IV, HK IV, HEXOKINASE-4, HK4, HEXOKINASE-D; COMPND 6 EC: 2.7.1.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GCK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS SUGAR KINASE, ALLOSTERIC ACTIVATOR, SMALL MOLECULE, TRANSFERASE- KEYWDS 2 TRANSFERASE ACTIVATOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.C.VOEGTLI REVDAT 4 28-FEB-24 4MLH 1 HETSYN REVDAT 3 29-JUL-20 4MLH 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 SITE REVDAT 2 23-OCT-13 4MLH 1 JRNL REVDAT 1 25-SEP-13 4MLH 0 JRNL AUTH R.J.HINKLIN,S.A.BOYD,M.J.CHICARELLI,K.R.CONDROSKI, JRNL AUTH 2 W.E.DEWOLF,P.A.LEE,W.LEE,A.SINGH,L.THOMAS,W.C.VOEGTLI, JRNL AUTH 3 L.WILLIAMS,T.D.AICHER JRNL TITL IDENTIFICATION OF A NEW CLASS OF GLUCOKINASE ACTIVATORS JRNL TITL 2 THROUGH STRUCTURE-BASED DESIGN. JRNL REF J.MED.CHEM. V. 56 7669 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 24015910 JRNL DOI 10.1021/JM401116K REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 13685 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.000 REMARK 3 FREE R VALUE TEST SET COUNT : 828 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3505 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.06400 REMARK 3 B22 (A**2) : 0.06400 REMARK 3 B33 (A**2) : -0.12900 REMARK 3 B12 (A**2) : -0.39700 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.003 REMARK 3 BOND ANGLES (DEGREES) : 0.650 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.423 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.546 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.805 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.016 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIGANDS.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MLH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000082059. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-SEP-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13772 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.27600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG1500, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 213.08000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 106.54000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 159.81000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 53.27000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 266.35000 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 213.08000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 106.54000 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 53.27000 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 159.81000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 266.35000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 11 REMARK 465 ALA A 12 REMARK 465 LEU A 13 REMARK 465 MET A 462 REMARK 465 LEU A 463 REMARK 465 GLY A 464 REMARK 465 GLN A 465 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 64 -79.95 -47.74 REMARK 500 GLU A 95 -77.43 58.40 REMARK 500 GLN A 106 133.29 -176.33 REMARK 500 ASP A 135 -72.55 -63.14 REMARK 500 GLN A 138 83.92 27.78 REMARK 500 ASN A 166 155.89 174.39 REMARK 500 LYS A 169 -7.69 67.00 REMARK 500 ALA A 173 116.03 -9.76 REMARK 500 ARG A 191 41.83 -68.99 REMARK 500 ARG A 192 -48.85 -158.81 REMARK 500 ALA A 282 0.68 -65.16 REMARK 500 ASN A 283 73.88 -159.30 REMARK 500 ILE A 293 -42.10 -132.44 REMARK 500 ASN A 313 57.25 39.04 REMARK 500 ARG A 397 99.43 168.87 REMARK 500 SER A 398 -145.62 36.69 REMARK 500 GLU A 399 150.15 145.51 REMARK 500 ASP A 400 -89.22 -155.14 REMARK 500 MET A 402 99.44 -67.30 REMARK 500 SER A 433 -8.92 72.93 REMARK 500 GLU A 443 79.80 49.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 399 ASP A 400 139.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MLE RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 PROTEIN CONSTRUCT IS RESIDUES 12-465 OF ISOFORM 2 (UNP P35557-2). DBREF 4MLH A 12 465 UNP P35557 HXK4_HUMAN 12 465 SEQADV 4MLH MET A 11 UNP P35557 INITIATING METHIONINE SEQRES 1 A 455 MET ALA LEU THR LEU VAL GLU GLN ILE LEU ALA GLU PHE SEQRES 2 A 455 GLN LEU GLN GLU GLU ASP LEU LYS LYS VAL MET ARG ARG SEQRES 3 A 455 MET GLN LYS GLU MET ASP ARG GLY LEU ARG LEU GLU THR SEQRES 4 A 455 HIS GLU GLU ALA SER VAL LYS MET LEU PRO THR TYR VAL SEQRES 5 A 455 ARG SER THR PRO GLU GLY SER GLU VAL GLY ASP PHE LEU SEQRES 6 A 455 SER LEU ASP LEU GLY GLY THR ASN PHE ARG VAL MET LEU SEQRES 7 A 455 VAL LYS VAL GLY GLU GLY GLU GLU GLY GLN TRP SER VAL SEQRES 8 A 455 LYS THR LYS HIS GLN MET TYR SER ILE PRO GLU ASP ALA SEQRES 9 A 455 MET THR GLY THR ALA GLU MET LEU PHE ASP TYR ILE SER SEQRES 10 A 455 GLU CYS ILE SER ASP PHE LEU ASP LYS HIS GLN MET LYS SEQRES 11 A 455 HIS LYS LYS LEU PRO LEU GLY PHE THR PHE SER PHE PRO SEQRES 12 A 455 VAL ARG HIS GLU ASP ILE ASP LYS GLY ILE LEU LEU ASN SEQRES 13 A 455 TRP THR LYS GLY PHE LYS ALA SER GLY ALA GLU GLY ASN SEQRES 14 A 455 ASN VAL VAL GLY LEU LEU ARG ASP ALA ILE LYS ARG ARG SEQRES 15 A 455 GLY ASP PHE GLU MET ASP VAL VAL ALA MET VAL ASN ASP SEQRES 16 A 455 THR VAL ALA THR MET ILE SER CYS TYR TYR GLU ASP HIS SEQRES 17 A 455 GLN CYS GLU VAL GLY MET ILE VAL GLY THR GLY CYS ASN SEQRES 18 A 455 ALA CYS TYR MET GLU GLU MET GLN ASN VAL GLU LEU VAL SEQRES 19 A 455 GLU GLY ASP GLU GLY ARG MET CYS VAL ASN THR GLU TRP SEQRES 20 A 455 GLY ALA PHE GLY ASP SER GLY GLU LEU ASP GLU PHE LEU SEQRES 21 A 455 LEU GLU TYR ASP ARG LEU VAL ASP GLU SER SER ALA ASN SEQRES 22 A 455 PRO GLY GLN GLN LEU TYR GLU LYS LEU ILE GLY GLY LYS SEQRES 23 A 455 TYR MET GLY GLU LEU VAL ARG LEU VAL LEU LEU ARG LEU SEQRES 24 A 455 VAL ASP GLU ASN LEU LEU PHE HIS GLY GLU ALA SER GLU SEQRES 25 A 455 GLN LEU ARG THR ARG GLY ALA PHE GLU THR ARG PHE VAL SEQRES 26 A 455 SER GLN VAL GLU SER ASP THR GLY ASP ARG LYS GLN ILE SEQRES 27 A 455 TYR ASN ILE LEU SER THR LEU GLY LEU ARG PRO SER THR SEQRES 28 A 455 THR ASP CYS ASP ILE VAL ARG ARG ALA CYS GLU SER VAL SEQRES 29 A 455 SER THR ARG ALA ALA HIS MET CYS SER ALA GLY LEU ALA SEQRES 30 A 455 GLY VAL ILE ASN ARG MET ARG GLU SER ARG SER GLU ASP SEQRES 31 A 455 VAL MET ARG ILE THR VAL GLY VAL ASP GLY SER VAL TYR SEQRES 32 A 455 LYS LEU HIS PRO SER PHE LYS GLU ARG PHE HIS ALA SER SEQRES 33 A 455 VAL ARG ARG LEU THR PRO SER CYS GLU ILE THR PHE ILE SEQRES 34 A 455 GLU SER GLU GLU GLY SER GLY ARG GLY ALA ALA LEU VAL SEQRES 35 A 455 SER ALA VAL ALA CYS LYS LYS ALA CYS MET LEU GLY GLN HET GLC A 501 12 HET VO2 A 502 22 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM VO2 3-(BENZYLOXY)-5-METHYL-N-(4-METHYL-1,3-THIAZOL-2-YL) HETNAM 2 VO2 PYRIDIN-2-AMINE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 GLC C6 H12 O6 FORMUL 3 VO2 C17 H17 N3 O S HELIX 1 1 THR A 14 ALA A 21 1 8 HELIX 2 2 GLU A 22 GLN A 24 5 3 HELIX 3 3 GLN A 26 GLY A 44 1 19 HELIX 4 4 PRO A 111 THR A 116 1 6 HELIX 5 5 THR A 118 HIS A 137 1 20 HELIX 6 6 ASN A 180 ARG A 191 1 12 HELIX 7 7 ASN A 204 TYR A 215 1 12 HELIX 8 8 GLN A 239 VAL A 241 5 3 HELIX 9 9 GLU A 256 PHE A 260 5 5 HELIX 10 10 LEU A 271 SER A 281 1 11 HELIX 11 11 TYR A 289 ILE A 293 5 5 HELIX 12 12 GLY A 294 ASP A 311 1 18 HELIX 13 13 LEU A 315 GLU A 319 5 5 HELIX 14 14 GLU A 331 GLU A 339 1 9 HELIX 15 15 ARG A 345 LEU A 355 1 11 HELIX 16 16 SER A 360 SER A 396 1 37 HELIX 17 17 GLY A 410 HIS A 416 1 7 HELIX 18 18 SER A 418 THR A 431 1 14 HELIX 19 19 GLU A 443 CYS A 457 1 15 SHEET 1 A 6 LEU A 58 ARG A 63 0 SHEET 2 A 6 ARG A 250 ASN A 254 -1 O ASN A 254 N LEU A 58 SHEET 3 A 6 CYS A 230 GLU A 237 -1 N TYR A 234 O VAL A 253 SHEET 4 A 6 CYS A 220 VAL A 226 -1 N GLY A 223 O CYS A 233 SHEET 5 A 6 MET A 402 ASP A 409 1 O GLY A 407 N MET A 224 SHEET 6 A 6 CYS A 434 GLU A 440 1 O THR A 437 N VAL A 406 SHEET 1 B 5 GLN A 98 SER A 109 0 SHEET 2 B 5 ASN A 83 GLU A 93 -1 N LEU A 88 O THR A 103 SHEET 3 B 5 GLY A 72 LEU A 79 -1 N PHE A 74 O VAL A 89 SHEET 4 B 5 PRO A 145 PHE A 150 1 O THR A 149 N LEU A 77 SHEET 5 B 5 ASP A 198 VAL A 203 1 O ALA A 201 N PHE A 148 SHEET 1 C 2 VAL A 154 ASP A 158 0 SHEET 2 C 2 LYS A 161 LEU A 164 -1 O LYS A 161 N GLU A 157 CRYST1 78.770 78.770 319.620 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012695 0.007330 0.000000 0.00000 SCALE2 0.000000 0.014659 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003129 0.00000